Abstract
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its urinary metabolite, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), are the most investigated carcinogenic biomarkers of tobacco-specific nitrosamines. Here, we report the development of a sensitive and selective assay based on liquid chromatography–tandem mass spectrometry (LC–MS/MS) to simultaneously measure urinary NNK and NNAL. With the use of isotope internal standards and online solid-phase extraction, urine samples were directly analyzed without prior sample purification. The detection limits of this method were 0.13 and 0.19 pg on column for NNK and NNAL, respectively. Inter- and intra-day imprecision was <10 %. Mean recovery of NNK and NNAL in urine was 99–100 %. This method was applied to measure urinary NNK and NNAL in 101 smokers and 40 nonsmokers to assess tobacco exposure. Urinary nicotine, cotinine, N3-methyladenine (N3-MeA), and N7-methylguanine (N7-MeG) were also measured by isotope-dilution LC–MS/MS methods. The results showed that urinary NNK was not observed in all smokers. Urinary free NNAL (0.10 ± 0.09 ng/mg creatinine) and total NNAL (0.17 ± 0.14 ng/mg creatinine) were detected in all smokers. Urinary concentrations of NNAL were significantly correlated with nicotine, cotinine, N3-MeA, and N7-MeG in smokers (P < 0.001). This method enables the direct and simultaneous measurement of NNK and NNAL in urine using only 50 μL of urine. This study first demonstrated in human that urinary tobacco-specific nitrosamines metabolite (NNAL) are highly correlated with their resulting methylated DNA lesions in urine, which may help to substantiate an increased cancer risk associated with tobacco smoke exposure.
Similar content being viewed by others
Abbreviations
- NNK:
-
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone
- NNAL:
-
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol
- SPE:
-
Solid-phase extraction
- LC–MS/MS:
-
Liquid chromatography–tandem mass spectrometry
- TSNA:
-
Tobacco-specific nitrosamine
- N3-MeA:
-
N3-methyladenine
- N7-MeG:
-
N7-methylguanine
- ESI:
-
Electrospray ionization
- LOD:
-
Limit of detection
- LOQ:
-
Limit of quantification
References
Adams JD, Brunneman KD, Hoffmann D (1983) Chemical studies on tobacco smoke: LXXV. Rapid method for the analysis of tobacco-specific N-nitrosamines by gas–liquid chromatography with a thermal energy analyzer. J Chromatogr 256:347–351
Alberg AJ, Brock MV, Samet JM (2005) Epidemiology of lung cancer: looking to the future. J Clin Oncol 23:3175–3185
Ashley DL, O’Connor RJ, Bernert JT, Watson CH, Polzin GM, Jain RB, Hammond D, Hatsukami DK, Giovino GA, Cummings KM (2010) Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers. Cancer Epidemiol Biomarkers Prev 19:1389–1398
Carmella SG, Akerkar SA, Hecht SS (1993) Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers’ urine. Cancer Res 53:721–724
Carmella SG, Akerkar SA, Richie JP Jr, Hecht SS (1995) Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers’ urine. Cancer Epidemiol Biomarkers Prev 4:635–642
Carmella SG, Le KA, Upadhyaya P, Hecht SS (2002) Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Chem Res Toxicol 15:545–550
Carmella SG, Han S, Fristad A, Yang Y, Hecht SS (2003) Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Cancer Epidemiol Biomarkers Prev 12:1257–1261
Chao MR, Wang CJ, Yang HH, Chang LW, Hu CW (2005) Rapid and sensitive quantification of urinary N7-methylguanine by isotope-dilution liquid chromatography/electrospray ionization tandem mass spectrometry with on-line solid-phase extraction. Rapid Commun Mass Spectrom 19:2427–2432
de Leon J, Diaz FJ, Rogers T, Browne D, Dinsmore L, Ghosheh OH, Dwoskin LP, Crooks PA (2002) Total cotinine in plasma: a stable biomarker for exposure to tobacco smoke. J Clin Psychopharmacol 22:496–501
De Weerd S, Thomas CM, Kuster JE, Cikot RJ, Steegers EA (2002) Variation of serum and urine cotinine in passive and active smokers and applicability in preconceptional smoking cessation counseling. Environ Res 90:119–124
Drabløs F, Feyzi E, Aas PA, Vaagbø CB, Kavli B, Bratlie MS, Peña-Diaz J, Otterlei M, Slupphaug G, Krokan HE (2004) Alkylation damage in DNA and RNA-repair mechanisms and medical significance. DNA Repair (Amst) 3:1389–1407
Goniewicz ML, Havel CM, Peng MW, Jacob P III, Dempsey D, Yu L, Zielinska-Danch W, Koszowski B, Czogala J, Sobczak A, Benowitz NL (2009) Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Cancer Epidemiol Biomarkers Prev 18:3421–3425
Goniewicz ML, Eisner MD, Lazcano-Ponce E, Zielinska-Danch W, Koszowski B, Sobczak A, Havel C, Jacob P, Benowitz NL (2011) Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking. Nicotine Tob Res 13:202–208
Harris JE (2004) Incomplete compensation does not imply reduced harm: yields of 40 smoke toxicants per milligram nicotine in regular filter versus low-tar cigarettes in the 1999 Massachusetts Benchmark Study. Nicotine Tob Res 6:797–807
Hecht SS (1998) Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 11:559–603
Hecht SS (1999) DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res 424:127–142
Hecht SS (2002) Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23:907–922
Hecht SS (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3:733–744
Hecht SS (2008) Progress and challenges in selected areas of tobacco carcinogenesis. Chem Res Toxicol 21:160–171
Hecht SS, Ye M, Carmella SG, Fredrickson A, Adgate JL, Greaves IA, Church TR, Ryan AD, Mongin SJ, Sexton K (2001) Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. Cancer Epidemiol Biomarkers Prev 10:1109–1116
Hoffmann D, Adams JD (1981) Carcinogenic tobacco-specific N-nitrosamines in snuff and in the saliva of snuff dippers. Cancer Res 41:4305–4308
Hu CW, Chang YZ, Wang HW, Chao MR (2010a) High-throughput simultaneous analysis of five urinary metabolites of areca nut and tobacco alkaloids by isotope-dilution liquid chromatography–tandem mass spectrometry with on-line solid-phase extraction. Cancer Epidemiol Biomarkers Prev 19:2570–2581
Hu CW, Chao MR, Sie CH (2010b) Urinary analysis of 8-oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2′-deoxyguanosine by isotope-dilution LC–MS/MS with automated solid-phase extraction: study of 8-oxo-7,8-dihydroguanine stability. Free Radic Biol Med 48:89–97
Hu CW, Lin BH, Chao MR (2011) Quantitative determination of urinary N3-methyladenine by isotope-dilution LC–MS/MS with automated solid-phase extraction. Int J Mass Spectrom 304:68–73
IARC (2007) Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC monographs on the evaluation of carcinogenic risks to humans, vol 89. International Agency for Research on Cancer, Lyon, France
Kavvadias D, Scherer G, Urban M, Cheung F, Errington G, Shepperd J, McEwan M (2009) Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urine. J Chromatogr B 877:1185–1192
Kelly JD, Inga A, Chen FX, Dande P, Shah D, Monti P, Aprile A, Burns PA, Scott G, Abbondandolo A, Gold B, Fronza G (1999) Relationship between DNA methylation and mutational patterns induced by a sequence selective minor groove methylating agent. J Biol Chem 274:18327–18334
Monti P, Traverso I, Casolari L, Menichini P, Inga A, Ottaggio L, Russo D, Iyer P, Gold B, Fronza G (2010) Mutagenicity of N3-methyladenine: a multi-translesion polymerase affair. Mutat Res 683:50–56
Richie JP Jr, Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS (1997) Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol Biomarkers Prev 6:783–790
Sasco AJ, Secretan MB, Straif K (2004) Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 45(Suppl 2):S3–S9
Shrivastav N, Li D, Essigmann JM (2010) Chemical biology of mutagenesis and DNA repair: cellular responses to DNA alkylation. Carcinogenesis 31:59–70
Stillwell WG, Glogowski J, Xu HX, Wishnok JS, Zavala D, Montes G, Correa P, Tannenbaum SR (1991) Urinary excretion of nitrate, N-nitrosoproline, 3-methyladenine, and 7-methylguanine in a Colombian population at high risk for stomach cancer. Cancer Res 51:190–194
Stokvis E, Rosing H, Beijnen JH (2005) Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not? Rapid Commun Mass Spectrom 19:401–407
Tamae K, Kawai K, Yamasaki S, Kawanami K, Ikeda M, Takahashi K, Miyamoto T, Kato N, Kasai H (2009) Effect of age, smoking and other lifestyle factors on urinary 7-methylguanine and 8-hydroxyguanosine. Cancer Sci 100:715–721
Wu W, Ashley DL, Watson CH (2003) Simultaneous determination of five tobacco-specific nitrosamines in mainstream cigarette smoke by isotope dilution liquid chromatography/electrospray ionization tandem mass spectrometry. Anal Chem 75:4827–4832
Xia Y, McGuffey JE, Bhattacharyya S, Sellergren B, Yilmaz E, Wang L, Bernert JT (2005) Analysis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine by extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Anal Chem 77:7639–7645
Yang YD (1998) Simultaneous determination of creatine, uric acid, creatinine and hippuric acid in urine by high performance liquid chromatography. Biomed Chromatogr 12:47–49
Yuan JM, Gao YT, Wang R, Chen M, Carmella SG, Hecht SS (2012) Urinary levels of volatile organic carcinogen and toxicant biomarkers in relation to lung cancer development in smokers. Carcinogenesis 33:804–809
Acknowledgments
We thank the National Science Council, Taiwan, for financial support (Grants NSC 99-2314-B-040-018-MY3 and NSC 100-2628-B-040-001-MY4).
Conflict of interest
None of the authors have any conflict of interest in relation to publication of this paper.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hu, CW., Hsu, YW., Chen, JL. et al. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC–MS/MS: evidence of linkage to methylated DNA lesions. Arch Toxicol 88, 291–299 (2014). https://doi.org/10.1007/s00204-013-1137-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-013-1137-y